|
|
||||||||
The Annals of Thoracic Surgery, Vol 58, 851-856, Copyright © 1994 by The Society of Thoracic Surgeons
JD Walker, FA Crawford Jr, R Mukherjee, MR Zile and FG Spinale
Recent studies have suggested that acute administration of 3, 5, 3'
triiodo-L-thyronine (T3) may increase ventricular performance; however, the
direct cellular effects of acute T3 administration are not understood. The
objectives of this study were to determine (1) whether T3 acts directly on
the cardiac muscle cell (myocyte) itself, and (2) whether T3 acts
independently of the myocyte beta-adrenergic receptor. Accordingly,
isolated myocyte function was examined using video- microscopy in normal
porcine myocytes (n = 60) in the control state and in the presence of
increasing T3 concentrations (10 to 500 pmol/L). T3 caused myocyte
shortening extent, shortening velocity, and lengthening velocity to
increase in a dose-dependent manner. For example, shortening velocity
increased from 49.2 +/- 4.3 microns/s at baseline to 66.5 +/- 6.1 microns/s
with 100 pmol/L T3 (p < 0.05). beta- Adrenergic stimulation with 25
nmol/L isoproterenol increased shortening velocity to 97.6 +/- 5.7
microns/s; isoproterenol with T3 increased shortening velocity further to
168.5 +/- 10.9 microns/s. Analysis of variance revealed that this increase
with T3 was independent of and additive to the beta-adrenergic receptor
system. In summary, T3 caused a dose-dependent increase in myocyte
contractile performance, and these effects were independent of and additive
to beta- adrenergic receptor stimulation. Thus, acute T3 administration may
provide a novel modality to improve left ventricular contractile function
independent of the beta-adrenergic receptor system.
ARTICLES
Direct effects of acute administration of 3, 5, 3' triiodo-L-thyronine on myocyte function
Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston 29425.
This article has been cited by other articles:
![]() |
E Mezosi, J Szabo, E V Nagy, A Borbely, E Varga, G Paragh, and Z Varga Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes J. Endocrinol., April 1, 2005; 185(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Sun, K. Ojamaa, W. A. Coetzee, M. Artman, and I. Klein Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E302 - E307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Klemperer, I. Klein, M. Gomez, R. E. Helm, K. Ojamaa, S. J. Thomas, O. W. Isom, and K. Krieger Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery N. Engl. J. Med., December 7, 1995; 333(23): 1522 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr, and F. G. Spinale 3,5,3'Triiodo-L-Thyronine Pretreatment With Cardioplegic Arrest and Chronic Left Ventricular Dysfunction Ann. Thorac. Surg., August 1, 1995; 60(2): 292 - 299. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford, and F. G. Spinale PRETREATMENT WITH 3,5,3' TRIIODO-L-THYRONINE (T3): Effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 315 - 327. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |